Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Juni 2018

Planlagt Fastgjort Låst Flyttet Genmab
2.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #259

    i remember reading that they have been very carefull in selecting their patients, also they are relatively young, the selection process apparantly took very long; is that what you were asking @
    Plimsoller ?

    1 Reply Last reply
    0
    • G Offline
      G Offline
      GeorgeBest
      wrote on sidst redigeret af
      #260

      Men BLUE og CELGENE vil givetvis gøre alt for at få det frem til mindst 3. linie. Ellers bliver deres investeringer aldrig rentable. Og så kan det jo tage noget fra dara

      1 Reply Last reply
      0
      • G Offline
        G Offline
        GeorgeBest
        wrote on sidst redigeret af
        #261

        Men generelt tror jeg ikke vi behøver frygte et CAR-T hype som vi sà efter ASH

        1 Reply Last reply
        0
        • P Offline
          P Offline
          Plimsoller
          wrote on sidst redigeret af
          #262

          Yes EL. Thank you. It was to assess whether it was an even playing field concerning the outcome of the trials. If the selection process is very biased it is certainly something to consider.

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #263

            have you seen the $ number EP Vantage put on bb2121? only
            $760mio in 2024....

            1 Reply Last reply
            0
            • P Offline
              P Offline
              Plimsoller
              wrote on sidst redigeret af
              #264

              @GB. Ja der er ikke noget at sige til at de vil frem i verden, men det skal jo være pga.et godt produkt, og ikke pga. hype.

              1 Reply Last reply
              0
              • P Offline
                P Offline
                Plimsoller
                wrote on sidst redigeret af
                #265

                Yes. It is very little and very late - and furthermore based

                1 Reply Last reply
                0
                • G Offline
                  G Offline
                  GeorgeBest
                  wrote on sidst redigeret af
                  #266

                  Enig. Men de vil gøre alt for at forsvare deres investering.

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    Plimsoller
                    wrote on sidst redigeret af
                    #267

                    on a very futuristiske assessment.

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      Plimsoller
                      wrote on sidst redigeret af
                      #268

                      Det forstår jeg godt, men data er med dara indtil videre:)

                      1 Reply Last reply
                      0
                      • G Offline
                        G Offline
                        GeorgeBest
                        wrote on sidst redigeret af
                        #269

                        CELGENE har jo satset vildt på CAR-T. De betalte også milliarder for Juno

                        1 Reply Last reply
                        0
                        • G Offline
                          G Offline
                          GeorgeBest
                          wrote on sidst redigeret af
                          #270

                          CELGENE betalte 9 milliarder USD for Juno. Sanseløst...

                          1 Reply Last reply
                          0
                          • B Offline
                            B Offline
                            bibob
                            wrote on sidst redigeret af
                            #271

                            Dara er et veltolereret MM drug og fortsætter med at bevise sit potientiale. CAR-T skal tilpasses den enkelte patient og vil være ( hvis det kommer helt frem i linierne ) alt for dyrt og som flere gange skrevet af dygtige skribenter her på sitet sandsynligvis kun til meget alvorligt angrebne patienter som ikke har andre muligheder. Sundhedssystemerne i de enkelte lande har jo ikke ubegrænsede midler til rådighed.

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #272

                              Niels van de Donk presentation on twitter https://twitter.com/mtmdphd/status/1002989064449069056 - https://twitter.com/mtmdphd/status/1002989447493967872 - https://twitter.com/mtmdphd/status/1002989970515259400

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #273

                                no further explanation on Dara/Atezo though

                                1 Reply Last reply
                                0
                                • G Offline
                                  G Offline
                                  GeorgeBest
                                  wrote on sidst redigeret af
                                  #274

                                  Hidtil er konsensus på ASCO også at CAR-T er rigtig godt til de meget sene linier. Jeg har ikke set onkologer eller lign argumentere for at det skal frem

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    Plimsoller
                                    wrote on sidst redigeret af
                                    #275

                                    Ok. Lad os håbe at nogle af CAR-T
                                    pengene kommer tilbage til Genmab.

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #276

                                      Barclays: Key takeaways from multiple myeloma physician dinner on BCMA CAR-T http://www.twitlonger.com/show/n_1sqi5um

                                      1 Reply Last reply
                                      0
                                      • G Offline
                                        G Offline
                                        GeorgeBest
                                        wrote on sidst redigeret af
                                        #277

                                        Bluebird og Genmab har iøvrigt exact samme markedsværdi. USD 9,15 milliarder. Sanseløst....

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #278

                                          CAR-T konceptet kan umuligt være en trussel for Dara.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger